Pink SheetTeva has agreed to pay $425m to resolve a four-year-old US Department of Justice accusation that the firm violated the False Claims Act and the Anti-Kickback Statute by using two foundations to funne
Generics BulletinThe countdown begins. The long-awaited merger between Sun Pharma and Taro Pharmaceutical is expected to be completed over the next month, as the latter’s shareholders approved the agreement by an
Pink SheetHector Armando Kellum, Sandoz’s former US VP of business contracting and analytics, has avoided jail time for his role in a US conspiracy to fix prices, rig bids, and allocate customers for generic
Generics BulletinTaro Pharmaceutical has asked a court in Manhattan to approve a $36m settlement to resolve a class action lawsuit claiming that the Sun Pharma subsidiary misled investors about its involvement in all